RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Clinical trials for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4 trials appear
Sign up with your email to follow new studies for RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fat cells fight brain cancer: new stem cell trial offers hope
Disease control Recruiting nowThis early-stage trial is testing whether stem cells from donated body fat can be safely injected into the brain during surgery to treat aggressive brain cancer that has returned. The study aims to find the safest dose and see if these cells can slow tumor growth and improve surv…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Drug-Radiation combo tested for aggressive brain cancers that return
Disease control Recruiting nowThis early-stage trial is testing whether combining an experimental drug called triapine with radiation therapy is safe for adults with glioblastoma or astrocytoma brain tumors that have returned after previous treatment. The study aims to find the highest dose of triapine that c…
Matched conditions: RECURRENT ASTROCYTOMA, IDH-MUTANT, GRADE 4
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC